A biological process by which an individual has biomarker evidence of amyloid-beta accumulation with elevated tracer retention on PET amyloid imaging and/or low amyloid-beta 42 in CSF assay, but no detectable evidence of additional brain alterations suggestive of neurodegeneration or subtle cognitive and/or behavioral symptomatology.

This is just here as a test because I lose it

Term information

hasDbXref

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220946/